• Intervacc released real-world monitoring results indicating strong protection from Strangvac, its vaccine against the potentially fatal equine disease strangles.
• Confirmed infections were rare among horses completing primary vaccination, including horses from stables with ongoing outbreaks.
• Strangvac has been available in Sweden, the EU and Britain since 2022.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intervacc AB published the original content used to generate this news brief via Cision (Ref. ID: 202611030230BITN____UKPR__SV_20261102-BIT-3578-0) on November 03, 2026, and is solely responsible for the information contained therein.